Excellent take on Drug Pricing as written by Dr. N. Adam Brown at MedPage Today. In 2016 the 21st Century Cures Act was passed by the House. The intent was to make it easier for pharmaceutical companies to bring new drugs to market and short cut the clinical trial processes. Health Affairs had this to say: “Still, we believe the bill’s potential benefits and modestly enhanced funding for scientific advancement are far outweighed by the increased...
Read More »